1. circ‑LRP6 contributes to osteosarcoma progression by regulating the miR‑141‑3p/HDAC4/HMGB1 axis
   Yali Yu et al, 2022, International Journal of Oncology CrossRef
2. Ginsenoside Rg1 relieves rat intervertebral disc degeneration and inhibits IL-1β-induced nucleus pulposus cell apoptosis and inflammation via NF-κB signaling pathway
   Lei Yu et al, 2024, In Vitro Cellular & Developmental Biology - Animal CrossRef
3. Emerging role and therapeutic implication of mTOR signalling in intervertebral disc degeneration
   Hai‐Wei Chen et al, 2023, Cell Proliferation CrossRef
4. Construction of a novel mRNA–miRNA–lncRNA/circRNA triple subnetwork associated with immunity and aging in intervertebral disc degeneration
   Wei Liu et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
5. Noncoding RNAs in skeletal development and disorders
   Qing Yao et al, 2024, Biological Research CrossRef
6. Stem Cells and Exosomes: New Therapies for Intervertebral Disc Degeneration
   Zoe Krut et al, 2021, Cells CrossRef
7. CircRNA RERE Promotes the Oxidative Stress-Induced Apoptosis and Autophagy of Nucleus Pulposus Cells through the miR-299-5p/Galectin-3 Axis
   Rong Wang et al, 2021, Journal of Healthcare Engineering CrossRef
8. Circ_LRP6 facilitates osteosarcoma progression via the miR‐122‐5p/miR‐204‐5p/HMGB1 axis
   Guanghui Wang et al, 2023, Environmental Toxicology CrossRef
9. Oxidative Stress in Intervertebral Disc Degeneration: New Insights from Bioinformatic Strategies
   Yongzhao Zhao et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
10. Long non‐coding RNA OIP5‐AS1 (Cyrano): A context‐specific regulator of normal and disease processes
    Serena Wooten et al, 2022, Clinical and Translational Medicine CrossRef
11. Can Manganese Dioxide Microspheres be Used as Intermediaries to Alleviate Intervertebral Disc Degeneration With Strengthening Drugs?
    Wentao Zhang et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
12. Downregulation of miR-760 Causes Human Intervertebral Disc Degeneration by Targeting the MyD88/Nuclear Factor-Kappa B Signaling Pathway
    Xueliang Cui et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef